Sotrovimab, the anti-viral medicine for COVID-19, is 100 per cent effective in preventing death, according to the latest study results released by MoHAP.
It showed that 97 per cent of the recipients recovered within 14 days and prevented ICU admission in 99 per cent of the cases.
The study was carried out between June 30 and July 13 in collaboration with the Abu Dhabi Department of Health and Dubai Health Authority (DHA).
Over 6,100 patients were given the anti-viral medicine, of which 52 per cent were aged 50 or above and had multiple pre-existing medical conditions.
The UAE was one of the first countries to receive the shipment of the medicine and had approved its use in June.
UAE air defences respond to incoming missile, drone threats
UAE joins five nations to urge adoption of UN resolution on maritime security
UAE sets up committee to document Iranian aggression, crimes
UAE and Egyptian Presidents discuss regional security, bilateral ties
MoHRE urges firms to meet Emiratisation compliance deadline
UAE, France reaffirm strategic partnership at Abu Dhabi dialogue
UAE President highlights 'Make It In The Emirates' as part of future vision
Sharjah Ruler opens AED700 million Khorfakkan Resort
